Forbes Medi-Tech Announces Product Launch with Kesko of Finland

Forbes Medi-Tech Announces Product Launch with Kesko of Finland Kesko of Finland has launched a range of yogurts incorporating Forbes' cholesterol-lowering ingredient, Reducol(tm), with product to be sold under "Pirkka" premium brand.
Home Naturade Significantly Strengthens Balance Sheet; Receives $2.5 Million in Capital from Westgate Equity Partners, L.P. Natrol Appoints Vincent Andrich VP Sales for Prolab Division Vermont Pure Holdings, Ltd. Announces Record Fiscal Year 2001 Results Body Shop Reports 24.8 Mil Euro Sales Revenues Spectrum Organic Products Responds to FDA Letter Regarding Use of Non-GMO Seal on Canola Oil Label Supplement Group Targets Consumer Education Advanced Nutraceuticals, Inc. Announces 2001 Year End Results And Additional Financing ADM Awarded Nutraceuticals Patent Patent Creates Proprietary Position for ADM in Fast-Growing Nutraceutical Market Tantivy Sciences Obtains Exclusive License to Unique Nutraceutical Products Top GNC Executives Tour Pittsburgh Market to Present New Business Plan and Expansion Possibilities; Meeting will focus on new business strategies and growth Nutrition 21 Receives Patent For the Nutritional Treatment of Type 2 Diabetes; Patent Presents New Pharmaceutical Licensing Opportunities ConsumerLab.com Finds Most B-vitamin Supplements Contain What They Claim, But Often Exceed Safe Levels - Consumers Cautioned to Be Aware of Side Effects with High Dose Products Nutraceutix, Inc., Nutravite Announcement Commercial Availability of CDT™ Glucosamine for Canadian Marketplace Harvey Kamil Appointed President of NBTY, Inc. - Scott Rudolph to Continue as Chairman and CEO drugstore.com Expects to Reach Profitability Target in 2003 Human Genome Project Leads to Innovative Healthcare NPIcenter’s Career Center targets nutraceutical Industry Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders Editorial: An Exercise in Synergy NBTY, Inc. Appoints Harvey Kamil President, Scott Rudolph To Continue As Chairman And CEO Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids LignisulMSM vs Naproxen for Osteoarthritis Clinical Trial Gets Underway Natural Health Trends Corp. Launches Lexxus Taiwan FDA Presents Compliance Guide for Structure/Function Claims New TrimFit® Bars Redefine Energy Bar Category New TrimFit® Bars Redefine Energy Bar Category Probiata® Offers Safe, Natural and Effective Alternative Alive & Well with Michelle Harris Be Well and Get Rewarded! Find Personalized Wellness Solutions and Earn Free Vitamins at NatureMade.com Consumers Search for Healthy Cleaning Products That Work Nordic Naturals: Omega 3 Fatty Acids Cyanotech Names Bob Capelli as Director of Sales Japanese Dietary Supplement Market Expands Japanese dietary supplement market expands based on a survey by Statistics Bureau of the Japanese Ministry of International Affairs and Communications reporting the results of its Family Income and Expenditure Survey of 2004. Japanese Dietary Supplement Market Expands Japanese dietary supplement market expands based on a survey by Statistics Bureau of the Japanese Ministry of International Affairs and Communications reporting the results of its Family Income and Expenditure Survey of 2004. Japanese Dietary Supplement Market Expands Japanese dietary supplement market expands based on a survey by Statistics Bureau of the Japanese Ministry of International Affairs and Communications reporting the results of its Family Income and Expenditure Survey of 2004. Japanese Dietary Supplement Market Expands Japanese dietary supplement market expands based on a survey by Statistics Bureau of the Japanese Ministry of International Affairs and Communications reporting the results of its Family Income and Expenditure Survey of 2004. Japanese Dietary Supplement Market Expands Japanese dietary supplement market expands based on a survey by Statistics Bureau of the Japanese Ministry of International Affairs and Communications reporting the results of its Family Income and Expenditure Survey of 2004. Biodar launches BetaCote(TM) 20VB in Europe Product is an advanced form of synthetic beta carotene designed for tablet-grade nutrition supplements and is free of all animal products Biodar launches BetaCote(TM) 20VB in Europe Product is an advanced form of synthetic beta carotene designed for tablet-grade nutrition supplements and is free of all animal products Biodar launches BetaCote(TM) 20VB in Europe Product is an advanced form of synthetic beta carotene designed for tablet-grade nutrition supplements and is free of all animal products Biodar launches BetaCote(TM) 20VB in Europe Product is an advanced form of synthetic beta carotene designed for tablet-grade nutrition supplements and is free of all animal products Biodar launches BetaCote(TM) 20VB in Europe Product is an advanced form of synthetic beta carotene designed for tablet-grade nutrition supplements and is free of all animal products Biodar launches BetaCote(TM) 20VB in Europe Product is an advanced form of synthetic beta carotene designed for tablet-grade nutrition supplements and is free of all animal products Sabinsa's ForsLean Brand Coleus Forskohlii Extract Not Connected With Product Contamination in Italy According to a recent notice issued by the Italian Regulatory Authority and the Medicines and Healthcare Products Regulatory Agency in the United Kingdom, a handful of adverse drug reaction reports have been filed in association with the use of Coleus forskohlii containing products in Italy; Sabinsa's ForsLean® brand Coleus forskohlii extract is not linked to contaminated products. Sabinsa's ForsLean Brand Coleus Forskohlii Extract Not Connected With Product Contamination in Italy According to a recent notice issued by the Italian Regulatory Authority and the Medicines and Healthcare Products Regulatory Agency in the United Kingdom, a handful of adverse drug reaction reports have been filed in association with the use of Coleus forskohlii containing products in Italy; Sabinsa's ForsLean® brand Coleus forskohlii extract is not linked to contaminated products. Sabinsa's ForsLean Brand Coleus Forskohlii Extract Not Connected With Product Contamination in Italy According to a recent notice issued by the Italian Regulatory Authority and the Medicines and Healthcare Products Regulatory Agency in the United Kingdom, a handful of adverse drug reaction reports have been filed in association with the use of Coleus forskohlii containing products in Italy; Sabinsa's ForsLean® brand Coleus forskohlii extract is not linked to contaminated products. Sabinsa's ForsLean Brand Coleus Forskohlii Extract Not Connected With Product Contamination in Italy According to a recent notice issued by the Italian Regulatory Authority and the Medicines and Healthcare Products Regulatory Agency in the United Kingdom, a handful of adverse drug reaction reports have been filed in association with the use of Coleus forskohlii containing products in Italy; Sabinsa's ForsLean® brand Coleus forskohlii extract is not linked to contaminated products. Sabinsa's ForsLean Brand Coleus Forskohlii Extract Not Connected With Product Contamination in Italy According to a recent notice issued by the Italian Regulatory Authority and the Medicines and Healthcare Products Regulatory Agency in the United Kingdom, a handful of adverse drug reaction reports have been filed in association with the use of Coleus forskohlii containing products in Italy; Sabinsa's ForsLean® brand Coleus forskohlii extract is not linked to contaminated products. Sabinsa's ForsLean Brand Coleus Forskohlii Extract Not Connected With Product Contamination in Italy According to a recent notice issued by the Italian Regulatory Authority and the Medicines and Healthcare Products Regulatory Agency in the United Kingdom, a handful of adverse drug reaction reports have been filed in association with the use of Coleus forskohlii containing products in Italy; Sabinsa's ForsLean® brand Coleus forskohlii extract is not linked to contaminated products. Sabinsa's ForsLean Brand Coleus Forskohlii Extract Not Connected With Product Contamination in Italy According to a recent notice issued by the Italian Regulatory Authority and the Medicines and Healthcare Products Regulatory Agency in the United Kingdom, a handful of adverse drug reaction reports have been filed in association with the use of Coleus forskohlii containing products in Italy; Sabinsa's ForsLean® brand Coleus forskohlii extract is not linked to contaminated products. Sabinsa's ForsLean Brand Coleus Forskohlii Extract Not Connected With Product Contamination in Italy According to a recent notice issued by the Italian Regulatory Authority and the Medicines and Healthcare Products Regulatory Agency in the United Kingdom, a handful of adverse drug reaction reports have been filed in association with the use of Coleus forskohlii containing products in Italy; Sabinsa's ForsLean® brand Coleus forskohlii extract is not linked to contaminated products. Sabinsa's ForsLean Brand Coleus Forskohlii Extract Not Connected With Product Contamination in Italy According to a recent notice issued by the Italian Regulatory Authority and the Medicines and Healthcare Products Regulatory Agency in the United Kingdom, a handful of adverse drug reaction reports have been filed in association with the use of Coleus forskohlii containing products in Italy; Sabinsa's ForsLean® brand Coleus forskohlii extract is not linked to contaminated products. Sabinsa's ForsLean Brand Coleus Forskohlii Extract Not Connected With Product Contamination in Italy According to a recent notice issued by the Italian Regulatory Authority and the Medicines and Healthcare Products Regulatory Agency in the United Kingdom, a handful of adverse drug reaction reports have been filed in association with the use of Coleus forskohlii containing products in Italy; Sabinsa's ForsLean® brand Coleus forskohlii extract is not linked to contaminated products. Lycopene Extract Draft Opinion Announced Agency’s expert advisers are calling for views on their draft opinion on allowing lycopene-rich tomato extract to be used as a novel food; The applicant, LycoRed, proposes to market its lycopene oleoresin for use as a novel food ingredient in a range of food products, including yoghurts, cheese, bread, sausages and cereal bars, at a level of 5 mg of lycopene per serving. Lycopene Extract Draft Opinion Announced Agency’s expert advisers are calling for views on their draft opinion on allowing lycopene-rich tomato extract to be used as a novel food; The applicant, LycoRed, proposes to market its lycopene oleoresin for use as a novel food ingredient in a range of food products, including yoghurts, cheese, bread, sausages and cereal bars, at a level of 5 mg of lycopene per serving. Lycopene Extract Draft Opinion Announced Agency’s expert advisers are calling for views on their draft opinion on allowing lycopene-rich tomato extract to be used as a novel food; The applicant, LycoRed, proposes to market its lycopene oleoresin for use as a novel food ingredient in a range of food products, including yoghurts, cheese, bread, sausages and cereal bars, at a level of 5 mg of lycopene per serving. Lycopene Extract Draft Opinion Announced Agency’s expert advisers are calling for views on their draft opinion on allowing lycopene-rich tomato extract to be used as a novel food; The applicant, LycoRed, proposes to market its lycopene oleoresin for use as a novel food ingredient in a range of food products, including yoghurts, cheese, bread, sausages and cereal bars, at a level of 5 mg of lycopene per serving. Lycopene Extract Draft Opinion Announced Agency’s expert advisers are calling for views on their draft opinion on allowing lycopene-rich tomato extract to be used as a novel food; The applicant, LycoRed, proposes to market its lycopene oleoresin for use as a novel food ingredient in a range of food products, including yoghurts, cheese, bread, sausages and cereal bars, at a level of 5 mg of lycopene per serving. Lycopene Extract Draft Opinion Announced Agency’s expert advisers are calling for views on their draft opinion on allowing lycopene-rich tomato extract to be used as a novel food; The applicant, LycoRed, proposes to market its lycopene oleoresin for use as a novel food ingredient in a range of food products, including yoghurts, cheese, bread, sausages and cereal bars, at a level of 5 mg of lycopene per serving. Lycopene Extract Draft Opinion Announced Agency’s expert advisers are calling for views on their draft opinion on allowing lycopene-rich tomato extract to be used as a novel food; The applicant, LycoRed, proposes to market its lycopene oleoresin for use as a novel food ingredient in a range of food products, including yoghurts, cheese, bread, sausages and cereal bars, at a level of 5 mg of lycopene per serving. Lycopene Extract Draft Opinion Announced Agency’s expert advisers are calling for views on their draft opinion on allowing lycopene-rich tomato extract to be used as a novel food; The applicant, LycoRed, proposes to market its lycopene oleoresin for use as a novel food ingredient in a range of food products, including yoghurts, cheese, bread, sausages and cereal bars, at a level of 5 mg of lycopene per serving. NSF International Appoints New Managing Director to Oversee European Operations Company announces the appointment of Koen Bontinck as managing director of NSF's European office in Brussels, Belgium, to mee public health and safety needs of clients in the European Union while expanding NSF's presence in new international markets. NSF International Appoints New Managing Director to Oversee European Operations Company announces the appointment of Koen Bontinck as managing director of NSF's European office in Brussels, Belgium, to mee public health and safety needs of clients in the European Union while expanding NSF's presence in new international markets. NSF International Appoints New Managing Director to Oversee European Operations Company announces the appointment of Koen Bontinck as managing director of NSF's European office in Brussels, Belgium, to mee public health and safety needs of clients in the European Union while expanding NSF's presence in new international markets. NSF International Appoints New Managing Director to Oversee European Operations Company announces the appointment of Koen Bontinck as managing director of NSF's European office in Brussels, Belgium, to mee public health and safety needs of clients in the European Union while expanding NSF's presence in new international markets. NSF International Appoints New Managing Director to Oversee European Operations Company announces the appointment of Koen Bontinck as managing director of NSF's European office in Brussels, Belgium, to mee public health and safety needs of clients in the European Union while expanding NSF's presence in new international markets. NSF International Appoints New Managing Director to Oversee European Operations Company announces the appointment of Koen Bontinck as managing director of NSF's European office in Brussels, Belgium, to mee public health and safety needs of clients in the European Union while expanding NSF's presence in new international markets. Incromega TG – Raising the Bar on Quality Company offers Incromega TG, an ultra high purity EPA & DHA omega-3 lipid concentrates, with 90% lower PCBs than industry wide CRN standards of 0.09 ppm. Incromega TG – Raising the Bar on Quality Company offers Incromega TG, an ultra high purity EPA & DHA omega-3 lipid concentrates, with 90% lower PCBs than industry wide CRN standards of 0.09 ppm. Incromega TG – Raising the Bar on Quality Company offers Incromega TG, an ultra high purity EPA & DHA omega-3 lipid concentrates, with 90% lower PCBs than industry wide CRN standards of 0.09 ppm. Incromega TG – Raising the Bar on Quality Company offers Incromega TG, an ultra high purity EPA & DHA omega-3 lipid concentrates, with 90% lower PCBs than industry wide CRN standards of 0.09 ppm. Incromega TG – Raising the Bar on Quality Company offers Incromega TG, an ultra high purity EPA & DHA omega-3 lipid concentrates, with 90% lower PCBs than industry wide CRN standards of 0.09 ppm. Peer-Reviewed Published Study Demonstrates Safety of UC-II® A recent study published in Toxicology Mechanisms and Methods demonstrates that UC-II®, InterHealth Nutraceuticals’ 40 mg, once-a-day, joint-health ingredient, is safe. Peer-Reviewed Published Study Demonstrates Safety of UC-II® A recent study published in Toxicology Mechanisms and Methods demonstrates that UC-II®, InterHealth Nutraceuticals’ 40 mg, once-a-day, joint-health ingredient, is safe. Peer-Reviewed Published Study Demonstrates Safety of UC-II® A recent study published in Toxicology Mechanisms and Methods demonstrates that UC-II®, InterHealth Nutraceuticals’ 40 mg, once-a-day, joint-health ingredient, is safe. Peer-Reviewed Published Study Demonstrates Safety of UC-II® A recent study published in Toxicology Mechanisms and Methods demonstrates that UC-II®, InterHealth Nutraceuticals’ 40 mg, once-a-day, joint-health ingredient, is safe. Peer-Reviewed Published Study Demonstrates Safety of UC-II® A recent study published in Toxicology Mechanisms and Methods demonstrates that UC-II®, InterHealth Nutraceuticals’ 40 mg, once-a-day, joint-health ingredient, is safe. Peer-Reviewed Published Study Demonstrates Safety of UC-II® A recent study published in Toxicology Mechanisms and Methods demonstrates that UC-II®, InterHealth Nutraceuticals’ 40 mg, once-a-day, joint-health ingredient, is safe. Peer-Reviewed Published Study Demonstrates Safety of UC-II® A recent study published in Toxicology Mechanisms and Methods demonstrates that UC-II®, InterHealth Nutraceuticals’ 40 mg, once-a-day, joint-health ingredient, is safe. Peer-Reviewed Published Study Demonstrates Safety of UC-II® A recent study published in Toxicology Mechanisms and Methods demonstrates that UC-II®, InterHealth Nutraceuticals’ 40 mg, once-a-day, joint-health ingredient, is safe. Peer-Reviewed Published Study Demonstrates Safety of UC-II® A recent study published in Toxicology Mechanisms and Methods demonstrates that UC-II®, InterHealth Nutraceuticals’ 40 mg, once-a-day, joint-health ingredient, is safe. BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate Jarrow Formulas® YouTube Channel Approaches 1 Million Views as Olympian-Endorsed Product Video Goes Viral The overwhelming popularity of the 26-second Olympian-endorsed product video, featuring short-track speed skater Katherine Reutter, reaps 1 million views for the Jarrow Formulas® YouTube Channel. Jarrow Formulas® YouTube Channel Approaches 1 Million Views as Olympian-Endorsed Product Video Goes Viral The overwhelming popularity of the 26-second Olympian-endorsed product video, featuring short-track speed skater Katherine Reutter, reaps 1 million views for the Jarrow Formulas® YouTube Channel. Jarrow Formulas® YouTube Channel Approaches 1 Million Views as Olympian-Endorsed Product Video Goes Viral The overwhelming popularity of the 26-second Olympian-endorsed product video, featuring short-track speed skater Katherine Reutter, reaps 1 million views for the Jarrow Formulas® YouTube Channel. Jarrow Formulas® YouTube Channel Approaches 1 Million Views as Olympian-Endorsed Product Video Goes Viral The overwhelming popularity of the 26-second Olympian-endorsed product video, featuring short-track speed skater Katherine Reutter, reaps 1 million views for the Jarrow Formulas® YouTube Channel. Jarrow Formulas® YouTube Channel Approaches 1 Million Views as Olympian-Endorsed Product Video Goes Viral The overwhelming popularity of the 26-second Olympian-endorsed product video, featuring short-track speed skater Katherine Reutter, reaps 1 million views for the Jarrow Formulas® YouTube Channel. Jarrow Formulas® YouTube Channel Approaches 1 Million Views as Olympian-Endorsed Product Video Goes Viral The overwhelming popularity of the 26-second Olympian-endorsed product video, featuring short-track speed skater Katherine Reutter, reaps 1 million views for the Jarrow Formulas® YouTube Channel. Jarrow Formulas® YouTube Channel Approaches 1 Million Views as Olympian-Endorsed Product Video Goes Viral The overwhelming popularity of the 26-second Olympian-endorsed product video, featuring short-track speed skater Katherine Reutter, reaps 1 million views for the Jarrow Formulas® YouTube Channel. ISO14001 certification granted to Indena Indena has been granted the ISO14001 certification for its main production site of Settala (Milan). ISO14001 certification granted to Indena Indena has been granted the ISO14001 certification for its main production site of Settala (Milan). ISO14001 certification granted to Indena Indena has been granted the ISO14001 certification for its main production site of Settala (Milan). ISO14001 certification granted to Indena Indena has been granted the ISO14001 certification for its main production site of Settala (Milan). ISO14001 certification granted to Indena Indena has been granted the ISO14001 certification for its main production site of Settala (Milan). New Company for “Change-The-World” Entrepreneurs™ Launches	~First Product Launched is Cholesterol-Lowering Yogurt with Reducol(tm)~ Vancouver, Canada Forbes Medi-Tech Inc. (TSX:FMI and NASDAQ:FMTI) today announced that Kesko of Finland has launched a range of yogurts incorporating Forbes' cholesterol-lowering ingredient, Reducol(tm). The yogurt, sold under the "Pirkka" premium brand name, is the first in a series of scheduled product launches planned for later this year incorporating Forbes' cholesterol-lowering ingredient into a variety of food matrices. "Kesko has made a strategic decision to invest in the development of healthy food products under the Pirkka premium brand. We see Reducol(tm) as one of the key components of this corporate strategy", says Harri Sivula, Deputy Managing Director of Kesko Food Ltd. "We are excited about the launch with an anticipated distribution to over 1000 stores and subsequent marketing programs with reach to virtually every household in Finland. We see the Pirkka / Reducol(tm) products evolving into the day-to-day purchases of our consumers who are focused on lowering their cholesterol levels." "With over EUR$7.5 billion in sales and over 1000 stores, Kesko provides an excellent venue for the first Reducol(tm)-based product launch in Europe", says Charles Butt, President and CEO of Forbes Medi-Tech Inc. "We look forward to working with Finland's largest grocery chain whose experience and established operations will be a tremendous asset in supporting this initial and future Reducol(tm)-enriched product launches." This business initiative with Kesko is the result of Forbes' Scandinavian partnership with Scanvit Ltd. of Finland, previously announced in November 2004. About Kesko Group Kesko Group (Kesko) is the leading provider of services in the Finnish trading sector and is also expanding its operations in the Nordic countries, the Baltic countries and Russia. The food trade is the largest of Kesko's divisions, accounting for over half of Kesko Group's net sales of over EUR$7.5 Billion. Kesko Food, operates in the grocery market offering diverse services to consumers and business customers in Finland and the Baltic countries. The key businesses of Kesko Food are the K-food store chain operations in Finland, Kespro Ltd's catering sales to HoReCa customers, and grocery retailing in the Baltic countries. For further information on Kesko, visit the website at www.kesko.com About Forbes Medi-Tech Inc. Forbes Medi-Tech Inc. is a life sciences company dedicated to the research, development and commercialization of innovative products for the prevention and treatment of cardiovascular disease. Our vision is to develop and market products along a treatment continuum that cardiovascular disease consumers, healthcare professionals and specialized cardiovascular disease research and healthcare institutions will identify, recommend and seek. Our business strategy is to develop and commercialize proprietary compounds to address the unmet needs of patients within the cardiovascular disease market. # # # NASDAQ and the Toronto Stock Exchange have not reviewed and do not accept responsibility for the adequacy or accuracy of the content of this News Release. The Company does not review or control the contents of any linked or referenced website, such links and references do not constitute an endorsement by Forbes of any other websites and Forbes is not responsible for the information contained on such websites. This News Release contains forward-looking statements regarding products containing Reducol(tm), the incorporation of Reducol(tm) in future products and the future launch of such products, which statements can be identified by the use of forward-looking terminology such as "scheduled", "planned", "anticipated", "we see", "evolving into", "look forward", or comparable terminology referring to future events or results. The Company's actual results could differ materially from those anticipated in these forward-looking statements as a result of numerous factors, including the risk of early termination of the Company's agreement with Scanvit or of Scanvit's agreement with Kesko; the Company's reliance on both Scanvit and Kesko for performance; uncertainty regarding the market for products containing Reducol(tm) and the risk that such products may not achieve market acceptance; product development risks; uncertainty whether further products containing Reducol(tm) will be launched later this year or at all; intellectual property risks; manufacturing risks and the Company's dependency on its joint venture manufacturing partner, Chusei (U.S.A.) Inc.; raw material supply risk; product liability and insurance risks; the effect of competition; and the Company's need for future funding; any of which could cause actual results to vary materially from current results or the Company's anticipated future results. See the Company's reports filed with the Canadian and U.S. securities regulatory authorities from time to time for cautionary statements identifying important factors with respect to such forward-looking statements, including certain risks and uncertainties, that could cause actual results to differ materially from results referred to in forward-looking statements. The Company assumes no obligation to update the information contained in this News Release.
Powered By Traffic Booster Absolute News Manager Plug-in by Xigla Software